PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women

被引：0
|
作者：
Obeidin, Farres [1 ]
Pincus, Jennifer [1 ]
Siziopikou, K. P. [2 ]
Blanco, Luis [3 ]
机构：
[1] Northwestern Mem Hosp, Chicago, IL 60611 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
224
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1, PD-1, and CTLA-4 Expression in Invasive Breast Cancer in Young Women
    Obeidin, Farres
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    MODERN PATHOLOGY, 2019, 32
  • [2] PD-L1 X CTLA-4 IN INVASIVE BLADDER CANCER
    Pereira, Fabiana
    Mattos, Tatiana
    Silva, Maria Antonieta
    Martini Filho, Dino
    Fernandes, Roni
    Toledo, Luis Gustavo
    Leitao, Luiz Felipe
    Montor, Wagner
    JOURNAL OF UROLOGY, 2021, 206 : E999 - E999
  • [3] PD-1 and PD-L1 Expression in Indian Women with Breast Cancer
    Bharadwa, Kishan R.
    Dasgupta, Kuheli
    Narayana, Suma Mysore
    Ramachandra, C.
    Babu, Suresh M. C.
    Rangarajan, Annapoorni
    Kumar, Rekha, V
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (01) : 21 - 29
  • [4] PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
    Porcellato, Ilaria
    Mecocci, Samanta
    Brachelente, Chiara
    Cappelli, Katia
    Armando, Federico
    Tognoloni, Alessia
    Chiaradia, Elisabetta
    Stefanetti, Valentina
    Mechelli, Luca
    Pepe, Marco
    Gialletti, Rodolfo
    Passeri, Benedetta
    Ghelardi, Alessandro
    Razzuoli, Elisabetta
    ANIMALS, 2021, 11 (07):
  • [5] Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
    Cheng, Weishi
    Kang, Kai
    Zhao, Ailin
    Wu, Yijun
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [6] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [7] PD-1/PD-L1/CTLA-4 INHIBITOR THERAPY FOLLOWING PROGRESSION ON A DIFFERENT PD-1/PD-L1 INHIBITOR: A CASE SERIES
    Mukkamala, Suresh
    Tawagi, Karine
    Matrana, Marc
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A121 - A121
  • [8] Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
    Skafi, Najwa
    Fayyad-Kazan, Mohammad
    Badran, Bassam
    GENE, 2020, 754
  • [9] Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma
    Landwehr, Laura-Sophie
    Altieri, Barbara
    Sbiera, Iuliu
    Remde, Hanna
    Kircher, Stefan
    Olabe, Julie
    Sbiera, Silviu
    Kroiss, Matthias
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (09): : 2325 - 2334
  • [10] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
12345